Please use this identifier to cite or link to this item: http://hdl.handle.net/11400/1445
Title: Endogenous estradiol, estrogen and progesterone receptors increase benign and breast cancer risk among non-familial postmenopausal females
Authors: Atoum, Manar
Al-Hourani, Huda
Nimer, Nisreen
Almuhrib, Tgreed
Raheem, Sabah
Item type: Conference publication
Keywords: Estradiol;Prolactin;Selective estrogen receptor modulators;Οιστρογόνα;Familial
Subjects: Medicine
Gynecology
Oncology
Midwifery
Ιατρική
Γυναικολογία
Ογκολογία
Μαιευτική
Issue Date: 20-Jul-2014
Dec-2012
Date of availability: 20-Jul-2014
Publisher: Μαρβάκη, Χριστίνα
Abstract: Background: Hormones and genetics play a critical role in breast cancer development, determining the association between plasma hormones and breast cancer risk among familial and non-familial females may provide insight into the etiology of breast cancer. Material and Methods: 140 postmenopausal females during the period between June 2007 and May 2011 were enrolled in this study, 83 were breast cancer patients and 57 were benign patients. Plasma estradiol, progesterone and prolactin levels were estimated among familial and non-familial breast cancer females. Estrogen and progesterone receptor status was determined for all breast cancer and benign females. Results: 20% of non-familial breast cancer and 16% of benign females have abnormal prolactin. 4% of non-familial breast cancer and 12% of benign females have abnormal progesterone. On the other hand, 57% of non-familial breast cancer females and 44% of non-familial benign females have abnormal serum estradiol. Plasma levels of estradiol were significantly associated with benign and breast cancer risk among both familial and non-familial females. While plasma levels of prolactin were significantly associated with breast cancer risk among non-familial females. Positive estrogen and progesterone receptors associated with increased benign or breast cancer risk among non-familial with high estradiol levels. Conclusion: Abnormal plasma estradiol and positive estrogen and progesterone receptors associated with increased risk among postmenopausal both among non familial benign and breast cancer females. These findings suggest that estradiol, prolactin and estrogen and progesterone receptors evaluation might be useful to better identify females with non-familial hormone-dependent disease that should be considered in breast cancer pathogenesis as well as in the treatments.
Language: English
Citation: Atoum, M., Al-Hourani, H., Nimer, N. & Almuhrib, T. (December 2012) Endogenous estradiol, estrogen and progesterone receptors increase benign and breast cancer risk among non-familial postmenopausal females. “Health Science Journal”. 6 (4). p. 693-702.
Journal: Health Science Journal
Type of Journal: With a review process (peer review)
Access scheme: Publicly accessible
License: Αναφορά Δημιουργού-Μη Εμπορική Χρήση-Όχι Παράγωγα Έργα 3.0 Ηνωμένες Πολιτείες
URI: http://hdl.handle.net/11400/1445
Appears in Collections:Τόμος 6, τεύχος 4 (Οκτ. - Δεκ. 2012)

Files in This Item:
File Description SizeFormat 
6410.pdf218.04 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons